Approved based on: Phase III NATALEE trial FDA Approval: Kisqali (ribociclib) in combination with an aromatase inhibitor (AI) for the...

Farxiga (Dapagliflozin) now approved in US for paediatric patients with type 2 diabetes aged 10 years and older USFDA approved...

Eli Lilly has announced the positive results from QWINT-2 and QWINT-4 Phase 3 clinical trials. The trial evaluated once-weekly Efsitora...

T2NOW Phase III study results were presented at the 59th Annual Meeting of the European Association for the Study of Diabetes (EASD)...